To evaluate the efficacy and safety of Shen Hai Long Capsule in the treatment of mild to moderate asthenospermia in men.
To evaluate the efficacy and safety of Shen Hai Long Capsule in the treatment of mild to moderate asthenospermia in men: 1) Efficacy index (1) Main efficacy indexes Forward motile sperm ratio (PR) (2) Secondary efficacy indexes 1. Sperm survival rate; 2. Sperm concentration; 3. Normal morphology rate of sperm; 4. Seminal malondialdehyde (MDA) 5. Seminal superoxide dismutase (SOD) 2) Safety indicators (1) Vital signs; (2) liver and kidney function; (3) blood routine; (4) electrocardiogram; (5) Adverse events.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
120
3 times/day (9 capsules/day) for 12 weeks
3 times/day (12 capsules/day) for 12 weeks
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China
Forward motile sperm ratio (PR)
To compare the PR between baseline and 12 weeks
Time frame: 12 weeks
Sperm survival rate
To compare the Sperm survival rate between baseline and 12 weeks
Time frame: 12 weeks
Sperm concentration
To compare the Sperm concentration between baseline and 12 weeks
Time frame: 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.